231 Efficacy of VEGFR2 targeted mAb therapy in preclinical cancer models resistant to antiangiogenic therapyDavid Surguladze,Mary Jane Plym, J Malaby,Marie Prewett,Mark Rutstein, Jessica Schwartz,David D S Lu,L Witte,James R TonraEjc Supplements(2010)引用 1|浏览15暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要